Hyperglycemia induces elevated expression of thyroid hormone binding protein in vivo in kidney and heart and in vitro in mesangial cells

Biochemical and Biophysical Research Communications

Volumn 391, Issue 4, 2010, Pages 1585-1591

  Al Kafaji, Ghada ^a   Malik, Afshan N ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Crystallin; CRYM; Diabetic nephropathy; Hyperglycemia; Oxidative stress; Thyroid hormone binding protein

Indexed keywords

GLUCOSE; HORMONE BINDING PROTEIN; HYBRID PROTEIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; THYROID HORMONE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FLUORESCENCE; GENETIC TRANSFECTION; GOTO KAKIZAKI RAT; HEART; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; KIDNEY CELL; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CLONING, MOLECULAR; CRYSTALLINS; DIABETIC NEPHROPATHIES; GLUCOSE; HUMANS; HYPERGLYCEMIA; KIDNEY; MEMBRANE PROTEINS; MESANGIAL CELLS; MYOCARDIUM; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; THYROID HORMONES;

RATTUS; RATTUS NORVEGICUS;

EID: 74449089357     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.061     Document Type: Article

References (40)

1. Schena F.B., and Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 16 (2005) S30-S33
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 4 (2001) 813-820
3. Brownlee M. The pathobiology of diabetic complications. Diabetes 54 (2005) 1615-1625
4. Nishikawa D., Edelstein X., Du L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
5. Cravedi P., and Remuzzi G. Treating the kidney to cure the heart. Kidney Int. Suppl. 111 (2008) S2-S3
6. Malik A.N., Zaidi Q., Morris C.A., et al. Cloning of abundantly expressed candidate diabetes associated kidney genes. J. Am. Soc. Nephrol. 8 (1997) A2995-A2997
7. C.A. Morris, The molecular biology of diabetic nephropathy, Ph.D. Thesis, University of Wales, 1997.
8. Kim R., Gasser R., and Wistow G. μ-Crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. Proc. Natl. Acad. Sci. USA 89 (1992) 9292-9296
9. Suzuki S., Suzuki N., Mori J.I., et al. Micro-Crystallin as an intracellular 3,5,3′-triiodothyrionine holder in vivo. Mol. Endocrinol. 21 (2007) 885-894
10. Oshima A., Suzuki S., Takumi Y., et al. THBP mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea. J. Med. Genet. 43 (2006) e25
11. Khalil A.A. Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci. 98 (2007) 766
12. Malinowski K., Cavaretta I.T., Susani M., et al. Identification of mu-crystallin as an androgen-regulated gene in human cancer. Prostate 69 (2009) 1109-1118
13. Forti S., Scanlan M., Invernizzi A., et al. Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum. Breast Cancer Res. Treat. 73 (2002) 245-256
14. Teixeira P.C., Iwai L.K., Kuramoto A.C.K., et al. Proteomic inventory of myocardial proteins from patients with chronic Chagas' cardiomyopathy. Braz. J. Med. Biol. Res. 39 (2006) 1549-1562
15. Yang J., Moravec C.S., Sussman M.A., et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102 (2000) 3046-3052
16. Fukada Y., Yasui K., Kitayama M., et al. Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1. Brain Res. 1160 (2007) 1-10
17. Reed P.W., Corse A.M., Porter N.C., et al. Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy. Exp. Neurol. 205 (2007) 583-586
18. Goto Y., Kakizaki M., and Maski N. Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc. Jpn. Acad. 51 (1975) 80-85
19. Goto Y., Kakizaki M., and Maski N. The spontaneous diabetes rat: a model of non-insulin-dependent diabetes mellitus. Proc. Jpn. Acad. 57 (1981) 381-384
20. Phillips A.O., Baboolal K., Riley S., et al. Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the goto Kakizaki model of non-insulin-dependent diabetes mellitus. Am. J. Kidney Dis. 37 2 (2001) 400-410
21. Malik A.N., Rossios C., Al-Kafaji G., et al. Glucose regulation of CDK7, a putative thiol related gene, in experimental diabetic nephropathy. Biochem. Biophys. Res. Commun. 25 (2007) 237-244
22. Malik A.N., and Al-Kafaji G. Glucose regulation of β-defensin 1 mRNA in human renal cells. Biochem. Biophys. Res. Commun. 353 (2007) 318-323
23. Gruden G., Perin P.C., and Camussi G. Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr. Diab. Rev. 1 (2005) 27-40
24. Page R., Morris C., William J., et al. Isolation of diabetes associated kidney genes using differential display. Biochem. Biophys. Res. Commun. 323 (1997) 49-53
25. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290 16 (2003) 2159-2167
26. Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv. Cardiol. 45 (2008) 1-16
27. Patricia W. Thyroid disease and diabetes. Clin. Diab. 18 (2000) 1-7
28. Kabadi U.M. Serum T3 and reverse T3 concentrations:indices of metabolic control in diabetes mellitus. Diab. Res. 3 (1986) 417-421
29. Bando Y., Ushiogi Y., Toya D., et al. Diabetic nephropathy accompanied by iodine-induced non-autoimmune hypothyroidism: two case reports. Endocr. J. 46 (1999) 803-810
30. Bando Y., Ushiogi Y., Okafuji K., et al. Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction. Exp. Clin. Endocrinol. Diab. 110 (2002) 408-415
31. Chen H.S., Wu T.E., Jap T.S., et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in type 2 diabetic patients. Diab. Med. 24 (2007) 1336-1341
32. Kaptein E.M. Thyroid hormone metabolism and thyroid disease in chronic renal failure. Endocr. Rev. 17 (1996) 45-63
33. van Hoek I., and Daminet S. Interactions between thyroid and kidney function in pathological conditions of these organ systems: a review. Gen. Comp. Endocrinol. 160 (2009) 205-215
34. Liu B., Bhat M., and Nagaraj R.H. AlphaB-crystallin inhibits glucose-induced apoptosis in vascular endothelial cells. Biochem. Biophys. Res. Commun. 321 (2004) 254-258
35. DeRubertis F.R., Cravens P.A., Melhem M.F., et al. Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 53 (2004) 762-768
36. Das K., and Chainy G.B. Modulation of rat liver mitochondrial antioxidant defense system by thyroid hormone. Biochem. Biophys. Acta 27 (2001) 1-13
37. Fernandez V., Tapia G., Varela P., et al. Redox up-regulated expression of rat liver manganese superoxide dismutase and Bcl-2 by thyroid hormone is associated with inhibitor of κB-α phosphorylation and nuclear factor-κB activation. J. Endocrinol. 186 (2005) 539-547
38. +/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox Signal. 10 (2008) 179-206
39. Pollak N., Dölle C., and Ziegler M. The power to reduce: pyridine nucleotides - small molecules with a multitude of functions. Biochem. J. 402 2 (2007) 205-218
40. Mori J., Suzuki S., Kobayashi M., et al. NADP-dependent cytosolic (T3) binding protein as a regulator for T(3) mediated transactivation. Endocrinology 143 (2002) 1538-1544